Multidisciplinary Cancer Investigation is a quarterly peer-reviewed journal focusing on all aspects of cancer research from bench to bedside. MCI aims to encourage comprehensive, multi-professional cancer research.

This journal is devoted to publishing substantial original studies with multidisciplinary approach in all areas of cancer research including basic and translational research, prevention, early detection, diagnosis, treatment, molecular and cellular biology, genetics, immunotherapy and regenerative medicine, biotechnology, epidemiology, psychological issues, rehabilitation, complementary and alternative medicine, medical ethics and law, informatics interventions, quality of life as well as novel engineering modalities in cancer therapy such as biomaterials, biophotonics, radiowave applications and bioelectronics medicine.

MCI received approval from the Commission for Accreditation & Improvement of Iranian Medical Journals according to certificate number 700/714 on 14 May 2017.

Main Image

Multidisciplinary Cancer Investigation

2022، Volume 6، Number 3

Print ISSN: 2476-4922

Electronic ISSN: 2538-1911

Editor-in-Chief: Keivan Majidzadeh-A

View The Current Issue

Accepted Articles


pISSN: 2476-4922
eISSN: 2538-1911


COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic, we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines, but we intend to be highly flexible at this time.

© 2022 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb